Larissa Prata - Concepedia

Author

Larissa Prata

Also Known As

L. Prata, Larissa G. Langhi Prata, Larissa G. P. Langhi, Larissa G. P. Langhi Prata, Larissa G. Prata, Larissa G.P. Langhi, Larissa G.P. Langhi Prata, Larissa Gutman Paranhos Langhi, Larissa Langhi, Larissa Langhi Prata

Publications

7.7K

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic Mayo Clinic in Florida WinnMed Mayo Clinic in Arizona The University of Texas Health Science Center at San Antonio

About

Larissa Prata is an author at Mayo Clinic specializing in medicine, cell biology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	480
2	Cell Biology	2	2	174
3	Health Sciences	1	1	153
4	Allergy	1	1	306
5	Biochemistry	1	1	153

Larissa Prata

Publications

4.2K

Citations

H-Index

Page 1

	Year	Citations
Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease LaTonya J. Hickson, Larissa Prata, Shane A. Bobart, EBioMedicine	2019	1.2K
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study Jamie N. Justice, Anoop M. Nambiar, Tamar Tchkonia, EBioMedicine	2019	1.1K
Targeting senescent cells alleviates obesity‐induced metabolic dysfunction Allyson K. Palmer, Ming Xu, Yi Zhu, Aging Cell	2019	632
Senolytics reduce coronavirus-related mortality in old mice Christina D. Camell, Matthew J. Yousefzadeh, Yi Zhu, Science Viral ImmunityViral PathogenesisImmunologyImmune RegulationImmunologic Mechanism	2021	306
Aged‐senescent cells contribute to impaired heart regeneration Fiona Lewis, Prashant J. Ruchaya, Eva Domenjo‐Vila, Aging Cell	2019	299
Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability Anoop M. Nambiar, Dean L. Kellogg, Jaime Justice, EBioMedicine	2023	207
Targeting p21Cip1 highly expressing cells in adipose tissue alleviates insulin resistance in obesity Lichao Wang, Binsheng Wang, Nathan Gasek, Cell Metabolism ObesityMetabolic SyndromeInsulin ResistanceInsulin SignalingSignal Transduction	2021	153
Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans Yi Zhu, Larissa Prata, Erin O. Wissler Gerdes, EBioMedicine	2022	85
SARS-CoV-2 causes senescence in human cells and exacerbates the senescence-associated secretory phenotype through TLR-3 Utkarsh Tripathi, Rayhane Nchioua, Larissa Prata, Aging	2021	84
Fisetin for <scp>COVID</scp> ‐19 in skilled nursing facilities: Senolytic trials in the <scp>COVID</scp> era Brandon P. Verdoorn, Tamara K. Evans, Gregory J. Hanson, Journal of the American Geriatrics Society	2021	49

Page 1